Owlstone Medical Limited

Owlstone Medical is a diagnostics company based in Cambridge, UK, founded in 2016 as a spin-out from Owlstone Inc. The company specializes in non-invasive breath-based diagnostics through its proprietary Breath Biopsy platform. This innovative approach aims to enable early disease detection and precision medicine, focusing on conditions such as cancer, respiratory diseases, liver disease, and asthma. The Breath Biopsy platform supports biomarker discovery and routine testing using advanced FAIMS technology. Owlstone Medical offers research products and services to academic and pharmaceutical partners, including Research Use Only panels for respiratory diseases. The company is also developing breath tests for various conditions, including lung cancer and digestive health. With over 100 patents and a significant investment backing, Owlstone Medical is committed to improving survival rates and healthcare outcomes through its pioneering diagnostic solutions.